A prize for making chemistry choose a side
Henri Kagan of France and Kenso Soai of Japan won the 2026 Nobel Prize in Chemistry Wednesday for work that showed how reactions can favor and amplify one mirror-image form of a molecule. Their discoveries became essential tools in modern organic chemistry and pharmaceutical manufacturing.
The Royal Swedish Academy of Sciences divided the prize equally “for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis.” Kagan, 95, is affiliated with Université Paris-Sud, while Soai, 76, is affiliated with Tokyo University of Science.
Why molecules can have a handedness
Some molecules come in two structures that contain the same atoms but cannot be placed exactly on top of each other—much like a left hand and a right hand. Chemists call that property chirality, from a Greek word for hand. Living systems often use only one of those forms, a pattern known as homochirality.
The distinction is not cosmetic. Two mirror-image versions can interact differently with receptors, enzymes and other biological structures. One can produce a desired effect while the other is inactive or harmful. Drugmakers therefore need reactions that reliably create the intended form rather than an uncontrolled mixture.
What Kagan and Soai discovered
Kagan helped establish principles showing that small differences in molecular handedness could create unexpectedly large effects in asymmetric reactions. His work demonstrated routes for producing one form with high selectivity and helped turn asymmetric synthesis into a practical field.
Soai later discovered a reaction in which a chiral product helps catalyze the creation of more molecules with the same handedness. That self-amplifying process, known as the Soai reaction, offered a striking demonstration of how a tiny initial imbalance can grow into a strong preference for one form.
Together, the discoveries addressed both a technical manufacturing problem and a deeper scientific question: how biological chemistry could come to favor one molecular orientation so strongly. The methods do not provide a single explanation for the origin of life’s handedness, but they show a mechanism by which an imbalance can emerge and reinforce itself.
Consequences for medicine
The importance of separating molecular forms became tragically clear through thalidomide, a sedative associated with severe birth defects in the 1960s. Later analysis showed that its mirror-image chemistry contributed to different biological effects. The case helped make control and testing of chiral compounds a central concern in drug development.
Modern medicines, fragrances and other specialty chemicals use asymmetric synthesis to improve purity and consistency. The American Chemical Society said Kagan and Soai enabled chemists to control molecular handedness with remarkable precision, influencing both fundamental research and products used in daily life.
The work also changed how chemists plan a synthesis. Instead of separating two forms only after a reaction is complete, researchers can design catalysts and conditions that favor the desired structure from the beginning, reducing waste and improving control over the final product.
The Nobel calendar
The chemistry announcement followed this week’s medicine and physics prizes. Literature, peace and economics announcements continue through October 12. Kagan and Soai will share 12 million Swedish kronor, approximately $1.2 million at the exchange rate cited by Reuters.
The laureates are scheduled to receive medals from Sweden’s King Carl XVI Gustaf in Stockholm on December 10, the anniversary of Alfred Nobel’s death. Their work illustrates a recurring feature of science prizes: research that begins with a subtle question about molecular structure can eventually reshape medicine and manufacturing around the world.
Sources: Reuters report on the 2026 Chemistry Nobel; American Chemical Society explanation of the laureates’ work. Reporting reviewed October 7, 2026.